Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:368-376
Published online before print July 5, 2007, doi: 10.1161/CIRCRESAHA.107.157537
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
101/4/368    most recent
CIRCRESAHA.107.157537v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parastatidis, I.
Right arrow Articles by Ischiropoulos, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parastatidis, I.
Right arrow Articles by Ischiropoulos, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-TYROSINE
*NITROGEN
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Genetically altered mice
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2007;101:368.)
© 2007 American Heart Association, Inc.


Molecular Medicine

Increased Protein Nitration Burden in the Atherosclerotic Lesions and Plasma of Apolipoprotein A-I–Deficient Mice

Ioannis Parastatidis, Leonor Thomson, Diana M. Fries, Ryan E. Moore, Junichiro Tohyama, Xiaoming Fu, Stanley L. Hazen, Harry F.G. Heijnen, Michelle K. Dennehy, Daniel C. Liebler, Daniel J. Rader, Harry Ischiropoulos

From the Stokes Research Institute and Departments of Pediatrics and Pharmacology (I.P., L.T., D.M.F., H.I.), Children’s Hospital of Philadelphia and The University of Pennsylvania, Philadelphia; the Department of Medicine (R.E.M., J.T., D.J.R.), The University of Pennsylvania, Philadelphia; the Department of Cardiovascular Medicine and Center for Cardiovascular Diagnostics and Prevention (X.F., S.L.H.), Cleveland Clinic Foundation, Cleveland Ohio; the Laboratory of Clinical Chemistry and Hematology and Cell Microscopy Center (H.F.G.H.), University Medical Center Utrecht, and Institute for Biomembranes, Utrecht, The Netherlands; the Department of Biochemistry and Mass Spectrometry Research Center (M.K.D., D.C.L.), Vanderbilt University School of Medicine, Nashville, Tenn; and the Department of Biological Chemistry (I.P.), School of Medicine, Aristotle University of Thessaloniki, Greece. Permanent address for L.T.: Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay. Current address for D.M.F.: Ministry of Health, Sao Paulo, SP, Brazil.

Correspondence to Harry Ischiropoulos, Stokes Research Institute, Children’s Hospital of Philadelphia, 416D Abramson Research Center, 34th Street Civic Center Boulevard, Philadelphia, PA 19104-4318. E-mail ischirop{at}mail.med.upenn.edu

Apolipoprotein A-I (apoA-I), the major protein constituent within high-density lipoprotein (HDL), has been associated with antiatherogenic protection by mechanisms that include reverse cholesterol transport and antiinflammatory functions. To evaluate the proposed protective function of apoA-I, proteins modified by nitrating oxidants were evaluated in the aortic tissue and plasma of mice lacking the low-density lipoprotein receptor and apobec (LA) and LA mice with genetic deletion of apoA-I (LA–apoA-I–/–). The levels of nitrated proteins in aortic tissue quantified by liquid chromatography with online electrospray ionization tandem mass spectrometry (LC/ESI/MS/MS) were 6-fold higher in the LA–apoA-I–/– as compared with the LA mice. The quantitative analyses were corroborated by immunohistochemical and high-resolution immunoelectron microscopic evaluation of the lesions, which revealed abundant staining for nitrated proteins in the aortic root lesions of LA–apoA-I–/– as compared with the LA mice. Proteomic approaches based on affinity enrichment and site-specific adduct mapping identified unique specific protein targets for nitration in the plasma of LA–apoA-I–/– that were not present in the plasma of LA mice. In particular the nitration of fibrinogen was shown to accelerate fibrin clot formation. Another consequence of the augmented levels of nitrated proteins was the induction of humoral responses documented by the increased circulating immunoglobulins that recognize nitrotyrosine in LA–apoA-I–/– as compared with the LA mice. These data collectively support a protective function of apoA-I diminishing the burden of nitrative oxidants in these mice models of atherosclerosis.


Key Words: atherosclerosis • tyrosine nitration • proteomics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Parastatidis, L. Thomson, A. Burke, I. Chernysh, C. Nagaswami, J. Visser, S. Stamer, D. C. Liebler, G. Koliakos, H. F. G. Heijnen, et al.
Fibrinogen {beta}-Chain Tyrosine Nitration Is a Prothrombotic Risk Factor
J. Biol. Chem., December 5, 2008; 283(49): 33846 - 33853.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Dhiman, E. S. Nakayasu, Y. H. Madaiah, B. K. Reynolds, J.-j. Wen, I. C. Almeida, and N. J. Garg
Enhanced Nitrosative Stress during Trypanosoma cruzi Infection Causes Nitrotyrosine Modification of Host Proteins: Implications in Chagas' Disease
Am. J. Pathol., September 1, 2008; 173(3): 728 - 740.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
B. A. Merrick
The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research
Brief Funct Genomic Proteomic, February 12, 2008; (2008) eln004v1.
[Abstract] [Full Text] [PDF]